A citizen gets a dose of influenza vaccine in San Francisco, California on October 16. The price of flu vaccine has surged due to a decreased supply of influenza vaccine. The shortage occurred following problems at a British plant. A current medical journal insists that manufacturing licenses, which were limited to a few suppliers, should have been given to more vaccine companies.